CO6531471A2 - Cápsulas resistentes a ácido - Google Patents

Cápsulas resistentes a ácido

Info

Publication number
CO6531471A2
CO6531471A2 CO12067580A CO12067580A CO6531471A2 CO 6531471 A2 CO6531471 A2 CO 6531471A2 CO 12067580 A CO12067580 A CO 12067580A CO 12067580 A CO12067580 A CO 12067580A CO 6531471 A2 CO6531471 A2 CO 6531471A2
Authority
CO
Colombia
Prior art keywords
capsules
acid resistant
weight
parts
gellan gum
Prior art date
Application number
CO12067580A
Other languages
English (en)
Inventor
Dominique Nicolas Cade
Xiongwei Daniel He
Original Assignee
Capsugel Begium Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Capsugel Begium Nv filed Critical Capsugel Begium Nv
Publication of CO6531471A2 publication Critical patent/CO6531471A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C41/00—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
    • B29C41/003—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor characterised by the choice of material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C41/00—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
    • B29C41/02—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor for making articles of definite length, i.e. discrete articles
    • B29C41/14—Dipping a core
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D22/00—Producing hollow articles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2001/00—Use of cellulose, modified cellulose or cellulose derivatives, e.g. viscose, as moulding material
    • B29K2001/08—Cellulose derivatives
    • B29K2001/12—Cellulose acetate
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2003/00—Use of starch or derivatives as moulding material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2005/00—Use of polysaccharides or derivatives as moulding material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2089/00—Use of proteins, e.g. casein, gelatine or derivatives thereof, as moulding material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/712—Containers; Packaging elements or accessories, Packages
    • B29L2031/7174—Capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se refiere a nuevas cápsulas farmacéuticas duras resistentes a ácido, un procedimiento para su fabricación, y al uso de dichas cápsulas particularmente pero no exclusivamente, para la administración oral de formulaciones farmacéuticas, productos veterinarios, alimento y complementos dietéticos a humanos o animales; las cápsulas de la invención se obtienen mediante composiciones acuosas que comprenden un polímero formador de película soluble en agua y goma de geIana, en una relación en peso mutua de 4 a 15 partes en peso de goma de gelana por 100 partes en peso de polímero formador de película.
CO12067580A 2009-09-24 2012-04-25 Cápsulas resistentes a ácido CO6531471A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24539209P 2009-09-24 2009-09-24

Publications (1)

Publication Number Publication Date
CO6531471A2 true CO6531471A2 (es) 2012-09-28

Family

ID=43027570

Family Applications (1)

Application Number Title Priority Date Filing Date
CO12067580A CO6531471A2 (es) 2009-09-24 2012-04-25 Cápsulas resistentes a ácido

Country Status (16)

Country Link
US (4) US8852631B2 (es)
EP (1) EP2480218B1 (es)
JP (1) JP5777625B2 (es)
KR (1) KR101762460B1 (es)
CN (1) CN102665697B (es)
AU (1) AU2010299527A1 (es)
BR (1) BR112012006651B1 (es)
CA (1) CA2775227C (es)
CO (1) CO6531471A2 (es)
DK (1) DK2480218T3 (es)
ES (1) ES2804779T3 (es)
MX (1) MX2012003540A (es)
PL (1) PL2480218T3 (es)
RU (1) RU2012116362A (es)
TW (1) TW201127370A (es)
WO (1) WO2011036601A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9700517B2 (en) 2009-09-24 2017-07-11 Capsugel Belgium Nv Acid resistant capsules

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140360404A1 (en) 2011-11-09 2014-12-11 Capsugel Belgium Nv Acid resistant banding solution for acid resistant two piece hard capsules
ES2728850T3 (es) 2012-05-02 2019-10-29 Capsugel Belgium Nv Dispersiones acuosas de acetato acetato succinato de hidroxipropilmetilcelulosa (HPMCAS)
WO2013175303A1 (en) * 2012-05-21 2013-11-28 Capsugel Belgium Nv Acid resistant banding solution for two piece hard capsules
WO2013174884A1 (en) 2012-05-23 2013-11-28 Capsugel France SAS Capsules having an incorporated taste modifying component
JP2014172850A (ja) 2013-03-07 2014-09-22 Capsugel Belgium Nv ハードカプセル製剤
JP6133702B2 (ja) * 2013-06-18 2017-05-24 紀州技研工業株式会社 インクジェットインキ、その製造方法及びその使用方法
EP3065720A1 (en) 2013-11-04 2016-09-14 Capsugel Belgium NV Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole
JP6060102B2 (ja) * 2014-03-13 2017-01-11 紀州技研工業株式会社 インクジェットインク及びその作製方法並びにインクジェットインクを用いた印字方法
CN103893772B (zh) 2014-04-21 2015-08-26 湖南尔康制药股份有限公司 一种羟丙基淀粉空心胶囊及其制备工艺
CN103937038B (zh) * 2014-04-28 2016-08-17 中国科学院化学研究所 用于制备空心胶囊的组合物及其淀粉基质空心胶囊
US20170216146A1 (en) * 2014-07-31 2017-08-03 Capsugel Belgium Nv Capsule formulation
JP6297441B2 (ja) * 2014-07-31 2018-03-20 森永乳業株式会社 ビフィドバクテリウム属細菌含有カプセルおよびその製造方法
EP3028694B1 (en) 2014-12-02 2017-07-12 Capsugel Belgium NV Dosage form articles for delayed release
WO2016105498A1 (en) 2014-12-23 2016-06-30 Synthetic Biologics, Inc. Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
CA2972979C (en) * 2015-01-13 2020-11-03 New Chapter, Inc. Vegetarian capsules containing supercritical herbal extracts
EP3566699A1 (en) 2015-11-10 2019-11-13 Capsugel Belgium NV Acid resistant banding or sealing solution for acid resistant two piece hard capsules
US20170157058A1 (en) * 2015-12-08 2017-06-08 Dah Feng Capsule Industry Co., Ltd. Acid resistant capsule shell composition, acid resistant capsule shell and its preparing process
EP3246000A1 (en) 2016-05-18 2017-11-22 Capsugel Belgium NV Separable capsule for sprinkling applications
EP3272340A1 (en) 2016-07-22 2018-01-24 Capsugel Belgium NV Acid resistant capsules
CA3151507C (en) 2016-08-24 2024-05-28 Prilenia Neurotherapeutics Ltd. Use of pridopidine for treating functional decline
JP2018199631A (ja) * 2017-05-26 2018-12-20 株式会社ファンケル ビフィズス菌含有カプセル製剤
BR112020000011A2 (pt) 2017-07-11 2020-07-21 Qualicaps Co., Ltd. cápsula dura entérica
CO2017007322A1 (es) * 2017-07-24 2019-01-31 Novamed S A Cápsulas duras resistentes al ácido con bajo contenido de coadyuvantes de gelificacion
CA3072032A1 (en) 2017-08-07 2019-02-14 Finch Therapeutics, Inc. Compositions and methods for maintaining and restoring a healthy gut barrier
US11083738B2 (en) 2017-09-28 2021-08-10 Natals, Inc. Dietary nutrient compositions
WO2019139891A1 (en) 2018-01-09 2019-07-18 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
KR20200125637A (ko) 2018-02-23 2020-11-04 크레스토보 홀딩스 엘엘씨 마이크로바이옴 관련 면역요법
EP3773686B1 (en) 2018-03-20 2023-06-07 Theriva Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
EP3768773A4 (en) * 2018-03-21 2022-11-30 Selby, Ryan Daniel VAPORIZER CAPSULES AND METHODS OF MAKING
EP3549578A1 (en) * 2018-04-06 2019-10-09 Bio Minerals N.V. Silicic acid formulation and use thereof
CN112566668A (zh) 2018-06-22 2021-03-26 快力胶囊股份有限公司 肠溶性硬胶囊
EP3632449A1 (en) 2018-10-05 2020-04-08 Bio Minerals N.V. Silicic acids for use in the treatment of periodontitis
KR102182326B1 (ko) * 2019-02-19 2020-11-24 주식회사 서흥 내산성 셀룰로오스 캡슐의 제조방법
WO2020182611A1 (en) * 2019-03-14 2020-09-17 Evonik Operations Gmbh Capsule shell comprising a core-shell polymer and a cellulose
WO2021011754A1 (en) 2019-07-18 2021-01-21 Synthetic Biologics, Inc. Intestinal alkaline phosphatase-based treatments of metabolic disorders
CN114502182A (zh) 2019-07-19 2022-05-13 芬奇治疗控股有限责任公司 用于治疗胃肠道病症的方法及产品
US20220331378A1 (en) 2019-09-13 2022-10-20 Finch Therapeutics Holdings Llc Compositions and methods for treating autism spectrum disorder
MX2022004515A (es) * 2019-10-16 2022-07-12 Capsugel Belgium Nv Metodo y composicion para aumentar la sintesis de proteinas musculares.
WO2021076920A1 (en) * 2019-10-16 2021-04-22 Capsugel Belgium Nv Method and composition for increasing muscle protein synthesis
EP4045630A1 (en) 2019-10-18 2022-08-24 Finch Therapeutics Holdings LLC Compositions and methods for delivering a bacterial metabolite to a subject
WO2021097288A1 (en) 2019-11-15 2021-05-20 Finch Therapeutics Holdings Llc Compositions and methods for treating neurodegenerative diseases
WO2021142353A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatitis b (hbv) and hepatitis d (hdv)
WO2021142358A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatic encephalopathy (he)
WO2021142347A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for non-alcoholic steatohepatitis (nash)
WO2021202806A1 (en) 2020-03-31 2021-10-07 Finch Therapeutics Holdings Llc Compositions comprising non-viable fecal microbiota and methods of use thereof
KR20230017192A (ko) * 2020-05-31 2023-02-03 에어젠 파마 엘티디. 경질 캡슐 투여 형태 및 이의 용도
WO2022055993A1 (en) * 2020-09-08 2022-03-17 The Johns Hopkins University Method of treatment of irritable bowel syndrome
US20240263251A1 (en) 2021-02-19 2024-08-08 Finch Therapeutics Holdings Llc Compositions and methods for providing secondary bile acids to a subject
JPWO2022244713A1 (es) * 2021-05-18 2022-11-24
JPWO2023100643A1 (es) 2021-11-30 2023-06-08
CN118340904A (zh) * 2024-04-19 2024-07-16 山东赫尔希胶囊有限公司 一种羟丙甲纤维素成膜组合物及其应用

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1144225A (en) 1965-09-07 1969-03-05 Dow Chemical Co Preparation of medicinal capsule shells from hydroxyalkyl-alkyl cellulose ethers
US4756902A (en) 1986-06-02 1988-07-12 Warner-Lambert Company Capsule sealing process and product
US5006346A (en) 1988-04-28 1991-04-09 Alza Corporation Delivery system
US5264223A (en) 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
JP3116602B2 (ja) 1992-10-06 2000-12-11 シオノギクオリカプス株式会社 硬質カプセル
US5431917A (en) 1992-10-08 1995-07-11 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
JPH07196478A (ja) 1993-12-30 1995-08-01 Hajime Sugii 安全性の高い食品及び医薬品用ソフトカプセル
US5756123A (en) 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
FR2757173A1 (fr) 1996-12-17 1998-06-19 Warner Lambert Co Compositions polymeres d'origine non-animale pour la formation de films
JP4249816B2 (ja) * 1997-02-24 2009-04-08 富士カプセル株式会社 ソフトカプセル
CA2307887A1 (en) 1997-10-31 1999-05-14 Monsanto Company Gellan gum tablet coating
JP3449253B2 (ja) 1998-10-29 2003-09-22 シオノギクオリカプス株式会社 硬質カプセルの製造方法
DE19926714A1 (de) 1999-01-25 2000-08-10 Su Heung Capsule Co Pflanzliche Steckkapseln und Verfahren für deren Herstellung
JP3716901B2 (ja) 1999-04-14 2005-11-16 シオノギクオリカプス株式会社 セルロースエーテルフィルム
US6294008B1 (en) 1999-04-21 2001-09-25 The Dow Chemical Company Haze-free cellulose ether capsules and process for making
DE60020716T2 (de) 1999-07-22 2005-12-15 Warner-Lambert Co. Llc Filmbildende zusammensetzungen aus pullulan
KR100379674B1 (ko) 2000-03-06 2003-04-10 주식회사 서흥캅셀 펙틴과 글리세린의 배합용액을 이용한 셀룰로오스 캅셀 및그의 제조방법
GB2366780A (en) 2000-07-07 2002-03-20 Bioprogress Tech Int Inc Foam capsules
EP1184033A1 (en) 2000-09-01 2002-03-06 Warner-Lambert Company Pectin film compositions
JP2002145783A (ja) 2000-11-06 2002-05-22 Kohjin Co Ltd Ｓ−アデノシルメチオニンまたはその塩類を含有するカプセル製剤
US20030072731A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
GB0221986D0 (en) 2002-09-21 2002-10-30 Bioprogress Technology Ltd Films with improved barrier properties
CN1694687A (zh) * 2002-10-22 2005-11-09 东门投资有限公司 胶囊和含阿拉伯树胶的成膜组合物
TW200520790A (en) 2003-12-22 2005-07-01 Dah Feng Capsule Industry Co Ltd The compositions of a vegetarian capsule shell
US20070298095A1 (en) 2004-05-24 2007-12-27 Shionogi Qualicaps Co., Ltd. Surface-Modified and Solubility-Improved Hard Capsule
WO2006043284A1 (en) 2004-10-21 2006-04-27 Sunil Mundra A process for manufacturing neutraceutical, pharmaceutical cellulose derivatives capsule
JPWO2006070578A1 (ja) 2004-12-28 2008-06-12 クオリカプス株式会社 硬カプセルのバンドシール
KR100661336B1 (ko) 2005-02-21 2006-12-27 주식회사 서흥캅셀 기계적 피막강도를 향상시킨 셀룰로오스 경질캅셀
WO2006136196A1 (en) * 2005-06-21 2006-12-28 V. Mane Fils Gellan seamless breakable capsule and process for manufacturing thereof
US20070043284A1 (en) 2005-08-16 2007-02-22 Robert Sanfilippo Medical electrode and method of use
EP1762232A1 (en) 2005-09-09 2007-03-14 Warner-Lambert Company LLC Liquid filled delivery system, preferably an HPMC capsule filled with glycerol
EP1983969A4 (en) 2006-01-24 2012-10-31 Qualicaps Co Ltd HUMIDITY LOW HUMIDITY CAPSULE AND METHOD FOR PRODUCING THE SAME
WO2007098612A1 (en) 2006-03-02 2007-09-07 Laboratoires Mauves Inc. Gastric acid resistant gelatin capsule composition and method for producing same
WO2008005742A2 (en) * 2006-06-30 2008-01-10 Mcneil-Ppc, Inc. Ibuprofen-containing liquid filled hard capsules
KR20120038021A (ko) * 2006-10-27 2012-04-20 화이자 프로덕츠 인코포레이티드 하이드록시프로필 메틸 셀룰로스 경질 캡슐 및 이의 제조 방법
GB0706178D0 (en) * 2007-03-29 2007-05-09 Univ Aston Enteric pharmaceutical capsules
EP2179728A4 (en) 2007-08-10 2013-01-23 Shanghai Huiyuan Vegetal Capsule Co Ltd NON-GELATINEOUS ENVELOPE MATERIAL FOR HARD CAPSULE AND PREPARATION METHOD
EP2223685A4 (en) 2007-11-13 2013-08-21 Shanghai Huiyuan Vegetal Capsule Co Ltd HARD-GEL CELLULAR, GASTRORESISTANT AND GELATIN-FREE ENVELOPE AND PROCESS FOR PREPARING THE SAME
JP5178236B2 (ja) * 2008-02-25 2013-04-10 クオリカプス株式会社 腸溶性カプセル
US8825387B2 (en) 2008-07-25 2014-09-02 Navteq B.V. Positioning open area maps
JP5253235B2 (ja) * 2009-03-02 2013-07-31 クオリカプス株式会社 腸溶性カプセル
RU2012102772A (ru) 2009-06-29 2013-08-10 МакНЕЙЛ-ППС, ИНК. Фармацевтическая таблетка, содержащая заполненную жидкостью капсулу
JP2013503847A (ja) 2009-09-04 2013-02-04 キャプシュゲル・ベルジウム・エヌ・ヴィ 着香カプセル
RU2012116362A (ru) 2009-09-24 2013-10-27 Кэпсьюджел Белджиум Нв Кислотоустойчивые капсулы
EP2750600B1 (en) 2011-09-14 2017-04-12 Capsugel Belgium NV Fill formulations and capsules and method of use to avoid migration of fill into or through the shell
JP2014172850A (ja) 2013-03-07 2014-09-22 Capsugel Belgium Nv ハードカプセル製剤
US20170216146A1 (en) 2014-07-31 2017-08-03 Capsugel Belgium Nv Capsule formulation
WO2016099921A1 (en) 2014-12-16 2016-06-23 E. I. Du Pont De Nemours And Company Films, fluoropolymer coated films and highly cleanable articles
TWI587880B (zh) 2015-03-24 2017-06-21 Can be made into the composition of enteric capsule shell, enteric capsule shell and its process
US9452141B1 (en) 2015-05-01 2016-09-27 Dah Feng Capsule Industry Co., Ltd. Acid resistant capsule shell composition, acid resistant capsule shell and its preparing process
US20170157058A1 (en) 2015-12-08 2017-06-08 Dah Feng Capsule Industry Co., Ltd. Acid resistant capsule shell composition, acid resistant capsule shell and its preparing process

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9700517B2 (en) 2009-09-24 2017-07-11 Capsugel Belgium Nv Acid resistant capsules

Also Published As

Publication number Publication date
US10874619B2 (en) 2020-12-29
EP2480218A1 (en) 2012-08-01
JP2013505928A (ja) 2013-02-21
US9700517B2 (en) 2017-07-11
US8852631B2 (en) 2014-10-07
RU2012116362A (ru) 2013-10-27
CA2775227C (en) 2017-12-19
JP5777625B2 (ja) 2015-09-09
EP2480218B1 (en) 2020-05-27
CN102665697B (zh) 2014-07-09
KR101762460B1 (ko) 2017-07-27
PL2480218T3 (pl) 2020-11-16
BR112012006651B1 (pt) 2021-11-03
DK2480218T3 (da) 2020-08-24
US10231934B2 (en) 2019-03-19
US20190175514A1 (en) 2019-06-13
US20170231918A1 (en) 2017-08-17
WO2011036601A1 (en) 2011-03-31
TW201127370A (en) 2011-08-16
AU2010299527A1 (en) 2012-04-19
ES2804779T3 (es) 2021-02-09
US20120288562A1 (en) 2012-11-15
MX2012003540A (es) 2012-09-07
KR20120079836A (ko) 2012-07-13
BR112012006651A2 (pt) 2020-08-11
US20150050334A1 (en) 2015-02-19
CA2775227A1 (en) 2011-03-31
CN102665697A (zh) 2012-09-12

Similar Documents

Publication Publication Date Title
CO6531471A2 (es) Cápsulas resistentes a ácido
BR112013000675A2 (pt) nanopartícula, processo para produzir uma nanopartícula compreendendo uma matriz de zeína e um aminoácido básico, processo para produzir uma nanopartícula compreendendo uma matriz de zeína, e um aminoácido básico e um composto biologicamente ativo solúvel em gordura, composição e produto alimentar
CY1116695T1 (el) Συνθεση περιεχοντας υπερ-μικρονοποιημενο παλμιτοϋλ-αιθανολαμιδιο
CO6640255A2 (es) Activadores de guanilato ciclasa soluble
MX336038B (es) Composiciones farmaceuticas de liberacion controlada de tapentadol.
BR112012021681A8 (pt) Rifaximina em pó, processo para preparação da mesma e composições de liberação controladas contendo a referida rifaximina útil para obtenção de um efeito de longa duração.
BR112012028291A2 (pt) composições farmacêuticas e métodos para sua produção
UY29395A1 (es) Formulación de medicamentos conteniendo vardenafilo.
JO3406B1 (ar) عملية لتصنيع منتج صيدلاني يشتمل على حمض الستريك ،أكسيد ماغنسيوم، بيكربونات بوتاسيوم وبيكو كبريتات صوديوم، تركيبة صيدلانية تشتمل على حبيبات متحصل عليها بواسطة هذه العملية ومنتجات وسيطة منها
BRPI0615195A8 (pt) preparação farmacêutica, embalagem, e, métodos para tratar doença gastrintestinal, para fabricar uma cápsula e para testar dissolução de cápsulas de balsalazida.
BR112014017756A8 (pt) Sistema de administração transmucosa para um medicamento
BR112013029677A2 (pt) estirpes de salmonella gallinarum avirulentas modificadas e composições farmacêuticas que utilizam as mesmas
TN2015000135A1 (en) Modified release formulations for oprozomib
ATE452120T1 (de) Fettsäure-benzenediol-derivate sowie herstellungs-und verwendungsverfahren dafür
NO20084478L (no) Konjugerte lipidderivater
CR11078A (es) Una composicion de liberacion prolongada que comprende un derivado de somatostatina en microparticulas
PH12016500693B1 (en) Slow-release solid oral compositions
BRPI0408848A8 (pt) Composições farmacêuticas de complexo de ciclodextrina-cladribina complexo, usos do referido complexo, bem como processos para a sua preparação
UA112345C2 (uk) Спосіб виготовлення за допомогою іонного желатинування інтестинальних альгінатних мікрокапсул, які містять диклофенак або одну із його солей, і багаточасткова фармацевтична композиція, що містить такі мікрокапсули
WO2009084041A3 (en) Pharmaceutical compositions of dexibuprofen
MX2012002631A (es) Capsulas con aroma.
CL2019000123A1 (es) Preparaciones de vitaminas que contienen galato de propilo.
BR112017019753A2 (pt) uso de composições de astaxantina, composição, processo para preparação de um produto alimentício ou ração, e, preparação medicinal
WO2009004039A3 (en) Hard gelatin capsule formulation comprising a pumpkin product
WO2009050555A3 (fr) Formulations de composes organoplatiniques en presence de polymeres associatifs, produits obtenus et leurs utilisations